Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05318092 · ClinicalTrials.gov registry record · NA
Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism
A NA study, sponsored by Angiodynamics.
- Completed
- Registry status
- NA
- Development phase
- 122
- Enrollment target
NCT05318092 is a NA study that has completed, run by Angiodynamics. The registered enrollment target is 122 participants.
The verdict
NCT05318092, a NA study, has completed, sponsored by Angiodynamics.
- COMPLETED
- Registry status
- NA
- Development phase
- 122 participants
- Enrollment target
Study Summary
To evaluate the safety and effectiveness of percutaneous mechanical aspiration thrombectomy using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE in a prospective trial of patients with acute intermediate-risk pulmonary embolism (PE).
Interventions
- DEVICE AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2022-10-19 |
| Est. Completion | 2024-01-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05318092
The ClinicalTrials.gov registry entry for NCT05318092 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Angiodynamics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE is the first listed.
NCT05318092 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05318092 about?
NCT05318092 is a clinical study titled "Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism". To evaluate the safety and effectiveness of percutaneous mechanical aspiration thrombectomy using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE in a prospective trial of patients with acute intermediate-risk pulmonary embolism (PE).
What is the current status of trial NCT05318092?
This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2022-10-19. Estimated completion is 2024-01-04.
What interventions are being tested in trial NCT05318092?
The interventions under investigation include: AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE (DEVICE).
Who is sponsoring clinical trial NCT05318092?
This trial is sponsored by Angiodynamics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.